Figure 5

Survey data for the VeressPLUS innovation related questions. (A) If the above claims are true, would you consider using the new VeressPLUS in patients with a normal BMI? (B) If the above claims are true, would you consider using the new VeressPLUS in patients with a high BMI? (C) Would you be interested in joining the VeressPLUS project as an innovator/early adapter?